Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
NightHawk Biosciences (NHWK)
NYSE MKT:NHWK
reports
NightHawk Biosciences (NHWK) Stock Price & Analysis
2,564 Followers
NHWK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $3.42
Previous Close$0.69
Volume19.00K
Average Volume (3M)42.82K
Market Cap
$17.97M
Enterprise Value-$3.17M
Total Cash (Recent Filing)$28.64M
Total Debt (Recent Filing)$9.10M
Price to Earnings (P/E)-0.4
Beta0.78
Next Earnings
Aug 09, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.87
Shares Outstanding26,049,209
10 Day Avg. Volume55,642
30 Day Avg. Volume42,818
Standard Deviation0.32
R-Squared0.00664
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.35
Price to Sales (P/S)23.12
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.46
Enterprise Value/Gross Profit1.07
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering2
NightHawk Biosciences News
Press ReleasesNightHawk Biosciences Provides Q1 2023 Business Update
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NHWK FAQ
What was NightHawk Biosciences’s price range in the past 12 months?
NightHawk Biosciences lowest stock price was $0.65 and its highest was $3.42 in the past 12 months.
What is NightHawk Biosciences’s market cap?
Currently, no data Available
When is NightHawk Biosciences’s upcoming earnings report date?
NightHawk Biosciences’s upcoming earnings report date is Aug 09, 2023 which is in 66 days.
How were NightHawk Biosciences’s earnings last quarter?
Currently, no data Available
Is NightHawk Biosciences overvalued?
According to Wall Street analysts NightHawk Biosciences’s price is currently Overvalued.
Does NightHawk Biosciences pay dividends?
NightHawk Biosciences does not currently pay dividends.
What is NightHawk Biosciences’s EPS estimate?
NightHawk Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NightHawk Biosciences have?
NightHawk Biosciences has 26,049,210 shares outstanding.
What happened to NightHawk Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NightHawk Biosciences?
Currently, no hedge funds are holding shares in NHWK
---
NightHawk Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.95%
12-Months-Change
Fundamentals
Return on Equity
-57.34%
Trailing 12-Months
Asset Growth
-19.91%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
NightHawk Biosciences
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.
---
Top 5 ETFs holding NHWK
iShares Core S&P Total U.S. Stock Market ETF
$8.25K
Up to five ETFs with an Outperform Smart Score that hold NHWK. The ETFs are listed according to market value of NHWK within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
TRACON Pharmaceuticals
―
Monopar Therapeutics Inc
―
Eledon Pharmaceuticals
―
BioCardia
―
Diamedica Therapeutics
―
---